Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Clasificación en acciones #18091
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Precio por acción
$4.47
Última sincronización: 2025-08-20
Capitalización bursátil
$213.06M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio CARGO Therapeutics, Inc. Common Stock (CRGX)

Categoría

Ratio P/B de CARGO Therapeutics, Inc. Common Stock (CRGX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de CARGO Therapeutics, Inc. Common Stock, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de CARGO Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH